Key result
Aripiprazole initiation in a child links to acute dystonia versus afebrile neuroleptic malignant syndrome.
Case Report (n=1)
Aripiprazole use in pediatric patients can be associated with severe adverse effects like acute dystonia or neuroleptic malignant syndrome, requiring rapid recognition by emergency physicians.
No takes yet. Share an insight, caveat, or question.
Urges rapid NMS recognition in children on antipsychotics; leaves open need for prospective pediatric safety data.
Sridaran et al. (2016) conducted a case report in Acute dystonia / Neuroleptic Malignant Syndrome (n=1). Aripiprazole was evaluated. Aripiprazole initiation in an 8-year-old child was associated with the development of an acute dystonic reaction versus neuroleptic malignant syndrome without fever.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: